Raltegravir | PULSE CLINIC - Asia's Leading Sexual Healthcare Network.

Raltegravir

12238

PEP : Post-Exposure Prophylaxis

Raltegravir

PEP : Post-Exposure Prophylaxis

Written by Icetim, Translated by Icetim and Dannie, Medically Approved by Dr. Wichakorn on 30 JUNE 2020

Trade Name: 
ISENTRESS®

Generic Name: 

Raltegravir 400 mg

Mechanism of Action: 
The drug inhibits the activity of HIV-1 integrase, which impedes the insertion of HIV-1 DNA into the host cell genome. Integrase is a vital enzyme that catalyzes two, which must occur for viral DNA insertion into the host DNA. Primarily, it removes two deoxynucleotides from the 3 ends of the viral DNA. When the reaction is complete, the enzyme is also responsible for covalently binding viral DNA to that of the host cell.
For more information, please Click

Indication: 
Raltegravir indicated in combination with other antiretroviral agents for the treatment of HIV-1 infection in adult patients. To improve the chance of fighting HIV-1 infection, raltegravir must be taken with other HIV medicines.
Indications and Usage, please Click

Other Indication: 
Post-Exposure Prophylaxis (PEP)

Side effect:
The most common side effects were insomnia, headache, nausea, dizziness, and fatigue.
The most commonly reported side effects included diarrhea, nausea, headache, nasopharyngitis, fatigue, abdominal pain, and vomiting
For more information, please Click

 

Drug Interaction:
There are 11 major drug interactions
aluminum carbonate
• aluminum hydroxide
 calcium carbonate
dihydroxyaluminum sodium carbonate
magaldrate
magnesium carbonate
magnesium hydroxide
rifampin
 zinc acetate
• zinc gluconate
• zinc sulfate
There are 4 disease interactions with raltegravir which include:
• hemodialysis
• liver disease
• myopathy/rhabdomyolysis
• PKU

For more drug interactions with Raltegravir, please Click

Pregnancy:
• Raltegravir should be used in pregnancy only if the potential benefit justifies the potential risk to the fetus. Raltegravir is classified as FDA pregnancy risk category C. 

• Breastfeeding is not recommended during use of this drug.

 

Alcohol, Drug and Supplement:
No alcohol and supplements interactions were found.

 

Availability:
Prescription only. Contact PULSE CLINIC.

 

References:
https://www.medicinenet.com/raltegravir 
https://www.drugs.com/drug-interactions/raltegravir-index.html
https://www.drugs.com/sfx/isentress-side-effects.html
http://www.antimicrobe.org/d98.asp 

Add us on Line and stay in touch.

LINE @pulseclinic

Add us on Line and stay in touch.

LINE @pulseclinic

Raltegravir 400 mg

Loading...

P u l s e Clinic Locations

Loading...